NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

They have already subtly communicated that the L trial is nearing completion and the combo trials are firing up. All of this in recent SEC filings.

No they did not.

Virtually any P3 trial will hit peak spend as most are being enrolling and early treatment. Then as the number on trial goes down the costs decrease. So the statement about costs decreasing simply means they are past that peak. The "completion" they are "nearing" (a word they never used) could be years away.

As far as the P1/2 combos, they have been financing to start that for most of this year.

On another issue, there is absolutely no hint of data anytime soon, yet you and others continue to spew that complete crap. Of course we all know how your fairy tale will evolve:

. Data soon (coming Sep)
. Trial is complete, but they must wait on the FDA (coming Dec,Jan)
. Have numbers, must wait on ASCO to release them(June)
. Big ASCO booth!!! Whoop it up.
. ASCO: how about these new P1 trials being launched with Direct+CIs. That is the real ticket.

Then we can wait for Sep, it comes every year.